Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T; EMPA-ICD investigators. Fujiki S, et al. Diabetes Ther. 2020 Nov;11(11):2739-2755. doi: 10.1007/s13300-020-00924-9. Epub 2020 Sep 23. Diabetes Ther. 2020. PMID: 32968947 Free PMC article.
Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel.
Goto H, Saito Y, Matsumoto T, Sato T, Yamashita D, Suzuki S, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Goto H, et al. Among authors: kobayashi y. J Atheroscler Thromb. 2023 Dec 1;30(12):1791-1802. doi: 10.5551/jat.64217. Epub 2023 Jun 13. J Atheroscler Thromb. 2023. PMID: 37316266 Free PMC article.
Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
Kitahara H, Yamashita D, Sato T, Suzuki S, Hiraga T, Yamazaki T, Matsumoto T, Kobayashi T, Ohno Y, Harada J, Fukushima K, Asano T, Ishio N, Uchiyama R, Miyahara H, Okino S, Sano M, Kuriyama N, Yamamoto M, Sakamoto N, Kanda J, Kobayashi Y. Kitahara H, et al. Among authors: kobayashi y, kobayashi t. J Cardiol. 2023 Sep;82(3):207-214. doi: 10.1016/j.jjcc.2023.06.002. Epub 2023 Jun 17. J Cardiol. 2023. PMID: 37336423
Factors associated with the uric acid-lowering effects of sodium-glucose cotransporter-2 inhibition in patients with type 2 diabetes: Insights from the randomized PROTECT trial.
Saito Y, Tanaka A, Imai T, Miura SI, Ajioka M, Kodama K, Kobayashi Y, Node K; PROTECT Investigators. Saito Y, et al. Among authors: kobayashi y. Diabetes Obes Metab. 2024 Mar;26(3):1110-1113. doi: 10.1111/dom.15368. Epub 2023 Nov 14. Diabetes Obes Metab. 2024. PMID: 37961042 No abstract available.
10,292 results
You have reached the last available page of results. Please see the User Guide for more information.